Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8622)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2020 (publication date) through Mar 12, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Dang H, Sun J, Wang G, Renner G, Layfield L, Hilli J. Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report. World J Clin Cases 2020; 8(18): 4100-4108 [PMID: 33024767 DOI: 10.12998/wjcc.v8.i18.4100] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Dang H, Sun J, Wang G, Renner G, Layfield L, Hilli J. Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report. World J Clin Cases 2020; 8(18): 4100-4108 [PMID: 33024767 DOI: 10.12998/wjcc.v8.i18.4100] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i18/4100.htm |
| Number | Citing Articles |
| 1 |
Barbara Ma, Niroshana Anandasabapathy. Immune Checkpoint Blockade and Skin Toxicity Pathogenesis. Journal of Investigative Dermatology 2022; 142(3): 951 doi: 10.1016/j.jid.2021.06.040
|
| 2 |
Naoki Kawakami, Hiroaki Saito, Susumu Takahashi, Shinpei Kajie, Rina Kato, Kazuhiro Shimaya, Yoko Wakai, Kazuhito Saito, Mai Sakashita. Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review. Seminars in Oncology 2022; 49(6): 439 doi: 10.1053/j.seminoncol.2023.01.003
|
| 3 |
Malek Shatila, Hao Chi Zhang, Anusha Shirwaikar Thomas, Antonio Pizuorno Machado, Sidra Naz, Nitish Mittal, Christine Catinis, Krishnavathana Varatharajalu, Carolina Colli Cruz, Eric Lu, Deanna Wu, Julie R Brahmer, Franck Carbonnel, Stephen B Hanauer, Bret Lashner, Bryan Schneider, John A Thompson, Michel Obeid, David P Farris, Yinghong Wang. Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events. Journal for ImmunoTherapy of Cancer 2024; 12(11): e009742 doi: 10.1136/jitc-2024-009742
|
| 4 |
Jarrett Rong, Faraz Jafri, Sean Ngo, Anirudha Chatterjee, Maria Julia Moura Nascimento Santos, Devin Garza, Hamza Salim, Raakhi Menon, Rachel Mortan, Andres Caleb Urias Rivera, Hao Chi Zhang, Anisha Patel, Cristhiam Rojas Hernandez, Yuanteng Jeff Li, Ajay Sheshadri, Ashley Aaroe, Afreen Shariff, Bryan Schneider, Anusha Thomas, Yinghong Wang. Rare irAEs associated with immune checkpoint inhibitor therapy. Expert Opinion on Drug Safety 2026; : 1 doi: 10.1080/14740338.2026.2629998
|
| 5 |
Siyuan Hao, Yixin Jin, Yue Yu, Jiantao Wang, Jing Zou, Yan Wang. Identification of potential molecular mechanisms and candidate drugs for radiotherapy- and chemotherapy-induced mucositis. Supportive Care in Cancer 2023; 31(4) doi: 10.1007/s00520-023-07686-7
|
| 6 |
Liuxian Yu, Jun Li, Yaxi Tang. Clinical characteristics, management, and prognosis of pembrolizumab-induced immune-related oral mucositis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1710588
|
| 7 |
|